Global Necrotizing Fasciitis Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 15090

Necrotizing fasciitis (NF), commonly known as flesh-eating disease, is an infection that results in the death of the body's soft tissue. It is a severe disease of sudden onset that spreads rapidly. Symptoms include red or purple skin in the affected area, severe pain, fever, and vomiting. The most commonly affected areas are the limbs and perineum.
Necrotizing fasciitis affects 0.4 to 1.0 person per 100,000 per year. Both sexes are affected equally. It becomes more common among older people and is very rare in children. Surgical debridement (cutting away affected tissue) is the mainstay of treatment for necrotizing fasciitis. Early medical treatment is often presumptive; thus, antibiotics should be started as soon as this condition is suspected. Cultures are taken to determine appropriate antibiotic coverage, and antibiotics may be changed when culture results are obtained. Besides blood pressure control and hydration, support should be initiated for those with unstable vital signs and low urine output.
In 2018, the global Necrotizing Fasciitis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Necrotizing Fasciitis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Necrotizing Fasciitis development in United States, Europe and China.

The key players covered in this study
Merck
Wockhardt
Atox Bio
Teva Pharmaceutical Industries
Basilea Pharmaceutica
Melinta Therapeutics
...

Market segment by Type, the product can be split into
Type I
Type II
Type III

Market segment by Application, split into
Hospital & Clinics
Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Necrotizing Fasciitis status, future forecast, growth opportunity, key market and key players.
To present the Necrotizing Fasciitis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Necrotizing Fasciitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Necrotizing Fasciitis Market Size Growth Rate by Type (2014-2025)
1.4.2 Type I
1.4.3 Type II
1.4.4 Type III
1.5 Market by Application
1.5.1 Global Necrotizing Fasciitis Market Share by Application (2014-2025)
1.5.2 Hospital & Clinics
1.5.3 Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Necrotizing Fasciitis Market Size
2.2 Necrotizing Fasciitis Growth Trends by Regions
2.2.1 Necrotizing Fasciitis Market Size by Regions (2014-2025)
2.2.2 Necrotizing Fasciitis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Necrotizing Fasciitis Market Size by Manufacturers
3.1.1 Global Necrotizing Fasciitis Revenue by Manufacturers (2014-2019)
3.1.2 Global Necrotizing Fasciitis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Necrotizing Fasciitis Market Concentration Ratio (CR5 and HHI)
3.2 Necrotizing Fasciitis Key Players Head office and Area Served
3.3 Key Players Necrotizing Fasciitis Product/Solution/Service
3.4 Date of Enter into Necrotizing Fasciitis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Necrotizing Fasciitis Market Size by Type (2014-2019)
4.2 Global Necrotizing Fasciitis Market Size by Application (2014-2019)

5 United States
5.1 United States Necrotizing Fasciitis Market Size (2014-2019)
5.2 Necrotizing Fasciitis Key Players in United States
5.3 United States Necrotizing Fasciitis Market Size by Type
5.4 United States Necrotizing Fasciitis Market Size by Application

6 Europe
6.1 Europe Necrotizing Fasciitis Market Size (2014-2019)
6.2 Necrotizing Fasciitis Key Players in Europe
6.3 Europe Necrotizing Fasciitis Market Size by Type
6.4 Europe Necrotizing Fasciitis Market Size by Application

7 China
7.1 China Necrotizing Fasciitis Market Size (2014-2019)
7.2 Necrotizing Fasciitis Key Players in China
7.3 China Necrotizing Fasciitis Market Size by Type
7.4 China Necrotizing Fasciitis Market Size by Application

8 Japan
8.1 Japan Necrotizing Fasciitis Market Size (2014-2019)
8.2 Necrotizing Fasciitis Key Players in Japan
8.3 Japan Necrotizing Fasciitis Market Size by Type
8.4 Japan Necrotizing Fasciitis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Necrotizing Fasciitis Market Size (2014-2019)
9.2 Necrotizing Fasciitis Key Players in Southeast Asia
9.3 Southeast Asia Necrotizing Fasciitis Market Size by Type
9.4 Southeast Asia Necrotizing Fasciitis Market Size by Application

10 India
10.1 India Necrotizing Fasciitis Market Size (2014-2019)
10.2 Necrotizing Fasciitis Key Players in India
10.3 India Necrotizing Fasciitis Market Size by Type
10.4 India Necrotizing Fasciitis Market Size by Application

11 Central & South America
11.1 Central & South America Necrotizing Fasciitis Market Size (2014-2019)
11.2 Necrotizing Fasciitis Key Players in Central & South America
11.3 Central & South America Necrotizing Fasciitis Market Size by Type
11.4 Central & South America Necrotizing Fasciitis Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Necrotizing Fasciitis Introduction
12.1.4 Merck Revenue in Necrotizing Fasciitis Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Wockhardt
12.2.1 Wockhardt Company Details
12.2.2 Company Description and Business Overview
12.2.3 Necrotizing Fasciitis Introduction
12.2.4 Wockhardt Revenue in Necrotizing Fasciitis Business (2014-2019)
12.2.5 Wockhardt Recent Development
12.3 Atox Bio
12.3.1 Atox Bio Company Details
12.3.2 Company Description and Business Overview
12.3.3 Necrotizing Fasciitis Introduction
12.3.4 Atox Bio Revenue in Necrotizing Fasciitis Business (2014-2019)
12.3.5 Atox Bio Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Company Details
12.4.2 Company Description and Business Overview
12.4.3 Necrotizing Fasciitis Introduction
12.4.4 Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2014-2019)
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 Basilea Pharmaceutica
12.5.1 Basilea Pharmaceutica Company Details
12.5.2 Company Description and Business Overview
12.5.3 Necrotizing Fasciitis Introduction
12.5.4 Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2014-2019)
12.5.5 Basilea Pharmaceutica Recent Development
12.6 Melinta Therapeutics
12.6.1 Melinta Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Necrotizing Fasciitis Introduction
12.6.4 Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2014-2019)
12.6.5 Melinta Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details